Jorge A. Narvaez Pardo , Agustina Freire , Marina C. Muñoz , Bruno Buchholz , Analía L. Tomat , Mariela M. Gironacci , Ulrike M. Steckelings , Natalia D. Magnani , Pablo A. Evelson , Fernando P. Dominici
{"title":"血管紧张素II型2受体激活可减轻慢性空气污染引起的炎症和氧化应激","authors":"Jorge A. Narvaez Pardo , Agustina Freire , Marina C. Muñoz , Bruno Buchholz , Analía L. Tomat , Mariela M. Gironacci , Ulrike M. Steckelings , Natalia D. Magnani , Pablo A. Evelson , Fernando P. Dominici","doi":"10.1016/j.etap.2025.104800","DOIUrl":null,"url":null,"abstract":"<div><div>The impact of chronic exposure to urban air (UA) on renin-angiotensin system (RAS) components and the therapeutic potential of the angiotensin type 2 receptor (AT<sub>2</sub>R) agonist, Compound 21 (C21), in mitigating pollution-induced inflammation and oxidative stress was evaluated in a mouse model exposed to UA for 14 weeks. Air pollution exposure increased pro-inflammatory cytokines and oxidative damage markers in the lungs and kidneys and upregulated angiotensin converting enzyme; ACE, and angiotensin type 1 receptor; AT<sub>1</sub>R in the lungs; while it induced a compensatory increase in Mas receptor; MasR and AT<sub>2</sub>R in the heart and kidneys. C21 treatment reduced IL-1β and TNF-α expression in the lungs and 3-nitrotyrosine levels in the lungs and kidneys, downregulated both ACE and AT<sub>1</sub>R expression in the lungs and increased renal MasR expression. Current results underscore the relevance of RAS dysregulation in pollution-induced tissue damage and positions AT<sub>2</sub>R agonism as a possibility for mitigating the health impacts of air pollution.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"119 ","pages":"Article 104800"},"PeriodicalIF":4.2000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Angiotensin II type 2 receptor activation alleviates inflammation and oxidative stress caused by chronic exposure to air pollution\",\"authors\":\"Jorge A. Narvaez Pardo , Agustina Freire , Marina C. Muñoz , Bruno Buchholz , Analía L. Tomat , Mariela M. Gironacci , Ulrike M. Steckelings , Natalia D. Magnani , Pablo A. Evelson , Fernando P. Dominici\",\"doi\":\"10.1016/j.etap.2025.104800\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The impact of chronic exposure to urban air (UA) on renin-angiotensin system (RAS) components and the therapeutic potential of the angiotensin type 2 receptor (AT<sub>2</sub>R) agonist, Compound 21 (C21), in mitigating pollution-induced inflammation and oxidative stress was evaluated in a mouse model exposed to UA for 14 weeks. Air pollution exposure increased pro-inflammatory cytokines and oxidative damage markers in the lungs and kidneys and upregulated angiotensin converting enzyme; ACE, and angiotensin type 1 receptor; AT<sub>1</sub>R in the lungs; while it induced a compensatory increase in Mas receptor; MasR and AT<sub>2</sub>R in the heart and kidneys. C21 treatment reduced IL-1β and TNF-α expression in the lungs and 3-nitrotyrosine levels in the lungs and kidneys, downregulated both ACE and AT<sub>1</sub>R expression in the lungs and increased renal MasR expression. Current results underscore the relevance of RAS dysregulation in pollution-induced tissue damage and positions AT<sub>2</sub>R agonism as a possibility for mitigating the health impacts of air pollution.</div></div>\",\"PeriodicalId\":11775,\"journal\":{\"name\":\"Environmental toxicology and pharmacology\",\"volume\":\"119 \",\"pages\":\"Article 104800\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-08-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Environmental toxicology and pharmacology\",\"FirstCategoryId\":\"93\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1382668925001759\",\"RegionNum\":3,\"RegionCategory\":\"环境科学与生态学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENVIRONMENTAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668925001759","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
Angiotensin II type 2 receptor activation alleviates inflammation and oxidative stress caused by chronic exposure to air pollution
The impact of chronic exposure to urban air (UA) on renin-angiotensin system (RAS) components and the therapeutic potential of the angiotensin type 2 receptor (AT2R) agonist, Compound 21 (C21), in mitigating pollution-induced inflammation and oxidative stress was evaluated in a mouse model exposed to UA for 14 weeks. Air pollution exposure increased pro-inflammatory cytokines and oxidative damage markers in the lungs and kidneys and upregulated angiotensin converting enzyme; ACE, and angiotensin type 1 receptor; AT1R in the lungs; while it induced a compensatory increase in Mas receptor; MasR and AT2R in the heart and kidneys. C21 treatment reduced IL-1β and TNF-α expression in the lungs and 3-nitrotyrosine levels in the lungs and kidneys, downregulated both ACE and AT1R expression in the lungs and increased renal MasR expression. Current results underscore the relevance of RAS dysregulation in pollution-induced tissue damage and positions AT2R agonism as a possibility for mitigating the health impacts of air pollution.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.